Test strip for screening early esophageal squamous cell carcinoma of high-risk groups
A technique for esophageal squamous cell carcinoma and test strips, which is applied in the field of medicine and biology, can solve problems such as rare application, achieve the effects of high sensitivity and specificity, reduce mortality, and improve detection rate
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050] Embodiment 1: the preparation of test strip
[0051] 1. Experimental materials
[0052] The bioactive raw materials used in the present invention are all commercially available products. Among them, CFHR3 monoclonal antibody was purchased from Shanghai Biological Yubo Biotechnology Co., Ltd., the article number is MAL329Hu21; CFHR3 polyclonal antibody was purchased from Shanghai Kemin Biotechnology Co., Ltd., article number K005454P; C1QTNF6 monoclonal antibody was purchased from Shanghai Qunji Biotechnology Co., Ltd. company, Cat. No. MAB16078; C1QTNF6 polyclonal antibody was purchased from Amigi Technology Co., Ltd., Cat. Aimeijie Technology Co., Ltd., catalog number H00005982-B01P.
[0053] PVC bottom plate, nitrocellulose membrane, glass fiber membrane, absorbent paper etc. are all existing commercially available products.
[0054] 2. Preparation of binding pads
[0055] (1) Preparation of colloidal gold:
[0056] Colloidal gold solution was prepared by trisodi...
Embodiment 2
[0080] Embodiment 2: the diagnostic value analysis of test strip
[0081] Use the test strip prepared in Example 1 of the present invention to detect the serum samples of patients with pathologically confirmed early esophageal squamous cell carcinoma and normal people, and evaluate and analyze the value of the test strip of the present invention for screening and diagnosis of early esophageal squamous cell carcinoma.
[0082] 1. Sample source
[0083] Serum samples were collected from the Henan Key Open Laboratory of Esophageal Squamous Cell Carcinoma in the First Affiliated Hospital of Zhengzhou University, including 80 samples of normal human serum (control group) and 80 serum samples of patients with early-stage esophageal squamous cell carcinoma (esophageal squamous cell carcinoma group). The sera of 80 normal people came from the healthy check-up population of the physical examination center of the laboratory's cooperative hospital, without any evidence of tumor-related. ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com